Pharma Journalist -

ReachBio Research Labs (trade name under ReachBio LLC), a CRO specializing in primary cell assay services and products, is now offering off-target toxicity and linker stability assay…
Read More...

CytomX Therapeutics, a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody therapeutic…
Read More...

Lonza announced the completion of a $15M multi-phase expansion of its solid oral dose development and manufacturing capabilities and capacity at its Tampa, FL (USA) site. The expansion…
Read More...

NeuroRx, Inc., a clinical stage biopharma company focused on development of drugs targeting depression and suicidality, announced that it has initiated a pivotal Phase 2b/3 study for…
Read More...

Altimmune, Inc. announced that it has entered into an agreement to acquire Spitfire Pharma, Inc. (Spitfire) including its product candidate SP-1373 (to be renamed ALT-801), a potent…
Read More...

ImaginAb Inc., a clinical stage immuno-oncology imaging company, announced that it has entered into a non-exclusive license and collaboration agreement with Roche. Under the terms of…
Read More...

Mirati Therapeutics, Inc. announced a clinical collaboration agreement with Novartis to evaluate the combination of MRTX849, Mirati's investigational KRAS G12C inhibitor and TNO155,…
Read More...

Lyndra Therapeutics, the company making daily pills a thing of the past, has announced a partnership with Gilead Sciences, Inc. to develop and commercialize ultra-long-acting oral HIV…
Read More...

Amidst a (r)evolution in pharmaceutical strategy, Real World Evidence is more than ever a key driver of growing innovation in product life cycle. Leading organizations are rethinking…
Read More...

SMi Report: Respiratory Drug Delivery conference will be taking place on 5th – 6th December 2019, the brochure is now available to download. With the rising prevalence of respiratory…
Read More...